Ebola Treatment Trial Begins in the DRC
A randomized, controlled Phase 2/3 trial testing multiple investigational Ebola therapies is enrolling patients with Ebola in the Democratic Republic of the Congo.
NIAID is committed to conducting HIV/AIDS research to prevent new infections, end HIV-related deaths and complications, and discover a cure.
NIAID Now Blog
Read about NIAID research advances and resources on the NIAID Now blog.